全文获取类型
收费全文 | 8920篇 |
免费 | 281篇 |
国内免费 | 40篇 |
专业分类
耳鼻咽喉 | 205篇 |
儿科学 | 743篇 |
妇产科学 | 376篇 |
基础医学 | 835篇 |
口腔科学 | 241篇 |
临床医学 | 754篇 |
内科学 | 1787篇 |
皮肤病学 | 400篇 |
神经病学 | 377篇 |
特种医学 | 192篇 |
外科学 | 1395篇 |
综合类 | 319篇 |
一般理论 | 3篇 |
预防医学 | 793篇 |
眼科学 | 173篇 |
药学 | 458篇 |
1篇 | |
中国医学 | 14篇 |
肿瘤学 | 175篇 |
出版年
2021年 | 36篇 |
2017年 | 60篇 |
2016年 | 43篇 |
2015年 | 77篇 |
2014年 | 78篇 |
2013年 | 121篇 |
2012年 | 166篇 |
2011年 | 175篇 |
2010年 | 144篇 |
2009年 | 172篇 |
2008年 | 134篇 |
2007年 | 126篇 |
2006年 | 132篇 |
2005年 | 92篇 |
2004年 | 40篇 |
2003年 | 44篇 |
2002年 | 52篇 |
2001年 | 64篇 |
2000年 | 38篇 |
1999年 | 78篇 |
1998年 | 164篇 |
1997年 | 193篇 |
1996年 | 212篇 |
1995年 | 164篇 |
1994年 | 161篇 |
1993年 | 161篇 |
1992年 | 95篇 |
1991年 | 115篇 |
1990年 | 108篇 |
1989年 | 122篇 |
1988年 | 96篇 |
1987年 | 114篇 |
1986年 | 89篇 |
1985年 | 71篇 |
1984年 | 72篇 |
1983年 | 60篇 |
1982年 | 51篇 |
1981年 | 61篇 |
1980年 | 48篇 |
1977年 | 43篇 |
1976年 | 40篇 |
1959年 | 343篇 |
1958年 | 759篇 |
1957年 | 868篇 |
1956年 | 771篇 |
1955年 | 803篇 |
1954年 | 780篇 |
1953年 | 39篇 |
1949年 | 182篇 |
1948年 | 125篇 |
排序方式: 共有9241条查询结果,搜索用时 15 毫秒
1.
J.A. Hannam S.J. Mitchell D. Cumin C. Frampton A.F. Merry M.R. Moore C.J. Kruger 《British journal of anaesthesia》2019,122(2):198-205
Background
Etomidate is frequently selected over propofol for induction of anaesthesia because of a putatively favourable haemodynamic profile, but data confirming this perception are limited.Methods
Patients undergoing cardiac surgery were randomised to induction of anaesthesia with propofol or etomidate. Phase I (n=75) was conducted as open-label, whereas Phase II (n=75) was double blind. Mean arterial blood pressure (MAP) and boluses of vasopressor administered after induction were recorded. The primary endpoint was the area under the curve below baseline MAP (MAP-time integral) during the 10 min after induction. Secondary endpoints were the use of vasopressors over the same period, and the effect of blinding on the aforementioned endpoints. Groups were compared using regression models with phase and anaesthetist as factors.Results
The mean difference between etomidate and propofol in the MAP-time integral below baseline was 2244 mm Hg s (95% confidence interval, 581–3906; P=0.009), representing a 34% greater reduction with propofol. Overall, vasopressors were used in 10/75 patients in the etomidate group vs 21/75 in the propofol group (P=0.38), and in 20/74 patients during the blinded phase vs 11/76 during the open-label phase (P=0.31). The interaction between randomisation and phase (open-labelled or blinded) was not significant for either primary (P=0.73) or secondary endpoints (P=0.90).Conclusions
Propofol caused a 34% greater reduction in MAP-time integral from baseline after induction of anaesthesia than etomidate, despite more frequent use of vasopressors with propofol, confirming the superior haemodynamic profile of etomidate in this context. The proportion of patients receiving vasopressors increased slightly, albeit not significantly, in both groups in the blinded phase.Clinical trial registration
Australian and New Zealand Clinical Trials Registry, ACTRN12614000717651. 相似文献2.
3.
Restriction fragment length polymorphism of human mitochondrial DNA in a sample population from Apulia (Southern Italy) 总被引:8,自引:1,他引:7
Restriction fragment length polymorphism (RFLP) of human mitochondrial DNA was analysed in a sample of 87 subjects from Apulia (South Italy) by the restriction enzymes Hpa I, Bam HI, Hae II, Msp I, Ava II, and Hinc II using total blood cell DNA probed by human mtDNA from placenta. Five BamHI morphs were observed, two of which are new ( Bam HI-4 and -5), as well as one new Ava II morph ( Ava II-28). The association Bam HI-4/ Ava II-28 enables us to demonstrate for the first time two polymorphic Bam HI sites present together in the same mtDNA molecule. In agreement with historical data the Apulian sample has been shown to be the most heterogeneous Italian population so far tested. 相似文献
4.
GIUSEPPE PERSEO MAURO GIGLI ROBERTO DE CASTIGLIONE 《Chemical biology & drug design》1987,29(4):478-485
The synthesis of TPH-13 (Glp-Glu-Lys-Pro-Tyr-Trp-Pro-Pro-Pro-Ile-Tyr-Pro-Met-OH), a tridecapeptide isolated from the skin of the South American frog Phyllomedusa rohdei, is described and alternative approaches are discussed. 相似文献
5.
Intratemporal vascular tumors: detection with CT and MR imaging 总被引:1,自引:0,他引:1
Lo WW; Shelton C; Waluch V; Solti-Bohman LG; Carberry JN; Brackmann DE; Wade CT 《Radiology》1989,171(2):445-448
The diagnostic contributions of computed tomography (CT) and magnetic resonance (MR) imaging were compared in 12 patients with benign intratemporal vascular tumors (hemangioma or vascular malformation). The tumors included six in the internal acoustic canal and six in the geniculate ganglion region. Clinical and histologic correlations were made. Two of the six patients with tumors in the internal acoustic canal underwent CT, and both required gas cisternography to show the tumor. Five patients in that group underwent MR imaging, and all five studies showed the tumor. All six patients with geniculate ganglion tumors underwent CT. Results in one study were questionable, and five showed the tumor. Five patients in this group underwent MR imaging, but the MR findings were positive in only two cases. MR imaging should therefore be performed before CT in the evaluation of facial nerve dysfunction, as it demonstrated all tumors in the internal acoustic canal and some in the geniculate ganglion region. If MR findings are negative, CT should then be performed to rule out a possible geniculate ganglion lesion. 相似文献
6.
L. TIMMER-DE MIK M.D. D.M. BROEKHUIJSEN-VAN HENTEN M.D. † J.M. OLDHOFF M.D. PH.D. D.B. DE GEER M.D. ‡ V. SIGURDSSON M.D. PH.D. S.G.M.A. PASMANS M.D. PH.D. 《Pediatric dermatology》2009,26(3):358-360
Abstract: In Sweet's syndrome, the essential features are the characteristic morphology of the lesions, their histologic appearance, the dramatic response to corticosteroids and the absence of scarring. We report an 8-month-old infant in whom Sweet's syndrome was diagnosed and who developed acquired cutis laxa in the skin lesions. 相似文献
7.
8.
9.
10.